Evofem Biosciences, Inc.
EVFM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9 | $53 | -$77 | -$205 |
| Dep. & Amort. | $1 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $3 | $9 |
| Change in WC | $1 | $5 | $6 | $11 |
| Other Non-Cash | $3 | -$70 | -$5 | $38 |
| Operating Cash Flow | -$4 | -$9 | -$70 | -$147 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$3 |
| Net Acquisitions | -$1 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$0 | -$0 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $4 | $6 | $0 |
| Stock Issued | $5 | $0 | $32 | $82 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $24 | $9 |
| Financing Cash Flow | $5 | $5 | $62 | $91 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$4 | -$9 | -$59 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $5 | $14 | $72 |
| End Cash | $1 | $1 | $5 | $14 |
| Free Cash Flow | -$4 | -$9 | -$71 | -$150 |